(S)-1-(o-Tolyl)butan-1-amine hydrochloride, 95.0%, 1g

3-bromo-5-ethyl-1,2,4-oxadiazole, 95.0%, 5g

1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 5g

3-Amino-4-chlorobenzamide, 97.0%, 1g

Pyrazine-2-thiol, 95.0%, 1g

Ethyl 5-bromo-1,4-dimethyl-1H-pyrazole-3-carboxylate, 95%, 1g

3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid, 98%, 1g

(R)-Methyl 2-amino-3-(4-aminophenyl)propanoate dihydrochloride, 95.0%, 1g

p-Cymene>95.0%(GC)500mL

(S)-1-(3,5-Dichloropyridin-4-yl)ethanol, 97.0%, 250mg

1-(4-BROMOPHENYL)CYCLOPENTANECARBOXYLIC ACID, 95.0%, 1g

1,3-Dibromo-5-(trifluoromethoxy)benzene, 98.0%, 100g

(Hexafluoro-2-hydroxyisopropyl)benzene, 99.0%, 5g